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Abstract
Background—To investigate the hypothesis that intrauterine growth restriction might produce a 
longstanding pro-inflammatory tendency, we investigated the association of low birth weight with 
blood levels of markers of inflammation and endothelial activation in middle-aged adults.
Methods—The ARIC Study enrolled subjects aged 45–64 years sampled from four U.S. 
communities. An inflammation/endothelial activation score from 0 to 6 was created, one point 
being given for each above-median value of white blood cell count, fibrinogen, von Willebrand 
factor and Factor VIII, and for each below-median value of albumin and activated partial 
thromboplastin time.
Results—Of the 9809 individuals reporting birth weight and having all inflammation/endothelial 
markers and covariates, 349 (3.6%) reported low birth weight (LBW). The mean (standard 
deviation) score was 3.5 (1.5) for those with and 3.1 (1.6) for those without LBW (p<0.001). In 
robust poisson regression models adjusting for gender, ethnicity, age, study center, educational 
level, and current drinking and smoking status and amount, those with LBW were more likely to 
have a high score (≥4 points) (RR=1.16, 95% CI: 1.05–1.29).
Conclusion—In the ARIC Study, LBW predicted greater inflammation and endothelial 
activation, as indicated by the higher score of blood markers, consistent with the hypothesis that 
early life events may result in a hyper-responsive innate immune system. Such a pro-inflammatory 
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tendency could help explain the association of low birth weight with elements of the metabolic 
syndrome and ischemic heart disease.
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1. Introduction
Intrauterine programming is hypothesized as a process through which a stimulus occurring 
during an intrauterine critical period of development leads to long-term alterations in genetic 
expression. Numerous cohort studies and experimental work in animals suggest that adverse 
conditions, such as undernutrition during fetal life, can lead to permanent adaptations in 
physiologic processes fundamental to future risk of coronary heart disease [1–4]. 
Atherosclerosis and other chronic diseases have thus been hypothesized to be “programmed” 
in utero [5,6]. However, the purported molecular and genetic mechanisms that link fetal 
adaptations to stressors such as undernutrition with disease in later life are not clearly 
understood.
Many studies suggest that inflammation plays an important role in the pathogenesis of 
atherothrombosis. Inflammatory cell infiltrates are common findings in chronic 
atherosclerosis, and evidence of immune activation in plaques has been shown [7]. 
Inflammation markers correlate with metabolic syndrome elements, and several causal 
mechanisms for inflammation in the pathogenesis of insulin resistance have been proposed 
[8–10]. Infection and other causes of environmental stress produce an activation of the 
innate immune system. If this activation occurs during a critical period for gene expression, 
it might produce a long-lasting or even permanent tendency for an increased pro-
inflammatory state. To test the hypothesis that low birth weight, a surrogate of 
environmental stress during such a critical period, might produce such a longstanding pro-
inflammatory tendency, we investigated whether low birth weight was associated with 
alteration in levels of markers of inflammation and endothelial activation in middle-aged 
adults.
2. Population and methods
The cohort component of the Atherosclerosis Risk in Communities (ARIC) Study is a 
prospective investigation of coronary heart disease (CHD) risk factors and the natural 
history of atherosclerosis. ARIC enrolled 15,792 white and African-American men and 
women ages 45–64 years selected by probability sampling from four U.S. communities 
(Forsyth County, North Carolina; Jackson, Mississippi; suburban Minneapolis, Minnesota; 
and Washington County, Maryland) and interviewed them initially between 1987 and 1989, 
as has been described elsewhere [11].
The 11,656 patients who attended the fourth visit in 1996–1998 (when questions about birth 
weight were included) were eligible for the present study. We excluded 4 individuals with 
ages outside the stated range, 927 individuals missing information on the covariates studied 
and, due to small numbers, 69 participants from minority ethnic groups. We additionally 
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excluded 638 individuals who reported being born prematurely and 209 who reported being 
a twin or had incomplete information on this variable. Thus, 9809 participants were included 
in the final analysis.
Participants were asked to provide their birth weight in pounds and ounces. If the participant 
did not know his or her exact birth weight, she/he was asked to provide birth weight into one 
of three categories: low, medium or high. As only 4779 (48.7%) participants recalled an 
exact birth weight, these data, when reported, were converted to the metric system and 
categorized into three groups (<2.5 kg, 2.5–4 kg and >4 kg). Both qualitative and 
quantitative birth weight variables were combined in one single variable used in analysis.
All additional information analyzed was obtained during the 1987–89 baseline exam, during 
which health status, family medical history, cardiovascular risk factors, employment and 
education were queried, anthropometrics and blood pressure were obtained and blood 
sampled for lipid, hemostasis, hematology and chemistry measurements [12].
With the exception of white blood cell count, all analyses were determined in central 
laboratories following standardized procedures. Albumin was measured using Coulter's 
bromcresol green colorimetric assay [13]. Hemostasis variables were analyzed in citrated 
samples. Fibrinogen was measured by the thrombin time titration method, with reagents and 
calibration reference (Fibriquick) from General Diagnostics (Organon-Technika Co, Morris 
Plains, NJ). Factor VIII coagulant activity was measured by a one-stage assay using factor 
VIII deficient plasma (George King Biomedical, Overland Park, KS). Von Willebrand factor 
antigen was assayed by enzyme-linked immunosorbent assay (American Bioproducts Co., 
Parsipanny, NJ); and activated partial thromboplastin time (aPTT) on an automated 
coagulometer. The reference material for assays was the Universal Coagulation Reference 
Plasma (Thromboscreen, Pacific Hemostasis, Ventura, CA). The reliability coefficient, 
based on repeated testing of individuals over 1–2 weeks, was 0.72 for fibrinogen, 0.86 for 
factor VIII activity, 0.68 for von Willebrand factor and 0.92 for aPTT. Counts of leukocytes 
were determined locally using automated particle counters.
A inflammation/endothelial activation score was created from six factors measured at 
baseline: white blood cell count, albumin, fibrinogen, aPTT, von Willebrand factor and 
Factor VIII, assigning 1 point for each of white blood cell count, fibrinogen, von Willebrand 
factor and Factor VIII having a value above the sample median, and also 1 point for each of 
albumin and aPTT having values below the median. This score thus ranged from 0 to 6.
Body mass index (BMI) was calculated as weight/height2 (kg/m2). Waist was measured at 
the umbilicus, hip circumference at its maximum, and waist–hip ratio (WHR) calculated as 
the ratio of the two. Systolic and diastolic blood pressure were determined as the mean of 
the second and third of three standardized measurements; hypertension defined as systolic 
blood pressure ≥140 mm Hg or diastolic ≥90 mm Hg and/or current use of anti-hypertension 
medication. We defined diabetes as a fasting value of ≥126 mg/dL or a non fasting value 
≥200 mg/dL, report of a physician diagnosis of diabetes, or use of anti-diabetes medications. 
Prevalent coronary heart disease was defined as a report of myocardial infarction, coronary 
bypass or balloon angioplasty, or a myocardial infarction detected on an adjudicated 
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baseline electrocardiogram. Educational level was categorized into 3 groups: advanced 
(attended or completed college, graduate or professional school); intermediate (completed 
high school); and basic (less than high school education). Participants were characterized as 
current, former or never drinkers, and current, former or never smokers. Cigarette years of 
smoking was estimated as the average number of cigarettes smoked per day times the 
number of years smoked.
Differences in levels of study factors between the three birth weight groups were compared 
using analysis of variance. Subsequently, since there were no significant differences 
between the high and medium birth weight groups, these two groups were merged, and 
reported analyses investigate differences between low vs. medium or high birth weight 
groups. Adjusted means were estimated as least-squares means of fixed effects using SAS 
PROC MIXED. Unadjusted differences were evaluated with t-tests. Chi-square testing was 
used to compare the distribution of inflammation/endothelial activation scores between 
those with low and those with medium or high birth weight.
We used multiple linear regression models to evaluate the adjusted association between 
categorical birth weight and each continuous markers of inflammation or endothelial 
activation. We then performed robust poisson regression to evaluate the adjusted association 
of low birth weight with having a high (≥4) number of above-median values for 
inflammation/endothelial activation markers [14]. In order to evaluate possible 
heterogeneity in associations, robust poisson regression models were performed separately 
in gender, ethnicity and disease (diabetes mellitus and prevalent ischemic heart disease) 
specific strata. All analyses were performed using SAS.
3. Results
Our sample consisted of 1235 (13%) African-American women, 4268 (43%) white women, 
642 (7%) African-American men and 3664 (37%) white men. Mean (standard deviation) age 
was 53.5 (5.62) years for women and 54.2 (5.72) years for men. There were 349 individuals 
(3.6%) in the low birth weight group and 9460 (96.4%) in the medium or high birth weight 
group. Table 1 presents the values for sociodemographic and clinical characteristics of the 
two groups adjusted for gender, race and age. Most reporting low birth weight were women. 
As adults, those with low birth weight were shorter, weighed less, drank less, showed higher 
levels of systolic blood pressure and had lower educational levels. African-Americans were 
more likely to report a low birth weight (4.5% vs. 3.3%). They also had higher values for 
vWF, VIII factor, fibrinogen and lower white blood count.
Table 2 shows the distribution of inflammation markers in the two birth weight groups by 
gender and adjusted for age and race. Both men and women with low birth weight had 
higher white cell counts. Women, additionally, presented higher fibrinogen and Factor VIII 
levels. Additionally, all other markers, with the exception of albumin, tended, though not 
statistically significantly so, toward a pro-inflammatory profile in the low birth weight 
group. Differences were larger in women.
Pellanda et al. Page 4













Mean levels of inflammation markers by birth weight categories were further adjusted in 
linear regression models for gender, ethnicity, age, study center, educational level, current 
drinking and current smoking status and lifetime cumulative amount smoked. In these 
models, those with low birth weight had 273 more white blood cells/mm3 (p=0.003) and 
4.7% greater factor VIII activity (p=0.01). The values for fibrinogen were 0.12 μmol/L 
higher (p=0.20), for aPTT 0.29 s shorter (p=0.08) and for von Willebrand factor antigen 
3.6% higher (p=0.12), although not statistically significantly so. Albumin levels did not 
differ between the groups (−0.004, p=0.78). Results were slightly stronger after further 
adjustment for BMI and WHR (data not shown). In models performed separately by gender, 
associations were similar, but tended to be somewhat stronger in women (data not shown).
As shown in Fig. 1, those with low birth weight had their distribution of inflammation/
endothelial activation scores shifted towards higher values than those with medium or high 
birth weights (p<0.001).
Table 3 shows the risks of a high inflammation and endothelial activation score for those 
with low birth weight in robust poisson regression models adjusted for gender, ethnicity, 
age, study center and factors associated with low birth weight which could potentially 
confound the association — educational level, current drinking and smoking status and 
lifetime cumulative amount smoked. Those with low birth weight had an increased risk of a 
high inflammation/endothelial activation score (RR=1.16, 95% CI: 1.05–1.29) compared to 
those with medium or high birth weight. This association was stronger for men 1.21 (95% 
CI: 0.96–1.54) than women 1.15 (95% CI: 1.02–1.28). The relative risk for the overall 
association with additional adjustment for BMI and WHR was 1.18 (95% CI: 1.07–1.31).
Low birth weight did not predict a higher inflammation/endothelial activation score in 
African-Americans (RR=0.93, 95% CI: 0.75–1.16). For whites, the relative risk was 1.27 
(95% CI: 1.13–1.41).
As misclassification of birth weight could occur in those who did not report exact weights, 
we reanalyzed the data including only the 4779 individuals who reported exact birth 
weights. This restriction yielded slightly stronger associations of low birth weight with a 
high inflammation/endothelial activation score, the relative risks being 1.22 (95% CI: 1.08–
1.38) when adjusted for gender, ethnicity, age, study center, educational level, current 
drinking and smoking status and lifetime cumulative amount smoked, and 1.23 (95% CI: 
1.09–1.40) with further adjustment for BMI and WHR.
African-Americans (35%) were less likely to recall an exact birth weight than whites (52%). 
However, we found no significant differences in the association between individuals 
reporting exact birth weight and those with qualitative data for either African-Americans or 
whites.
4. Discussion
In this population-based study of middle-aged individuals, an aggregate of markers of 
inflammation and endothelial activation, and, among them, most notably white cell count 
and factor VIII, were higher in those with low reported birth weight. The few studies that 
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have investigated the association between low birth weight and subsequent levels of 
inflammation markers had contradictory findings. However, most of these studies were 
small. A study with 77 pairs of twins failed to demonstrate an association of birth weight 
with fibrinogen and albumin excretion rate [15], and one study in 641 children aged 10–11 
years reported the lack of association between birth weight and fibrinogen [16] and C-
reactive protein (CRP) levels [17].
In adults, the report of Martyn et al. is consistent with our findings, showing that plasma 
concentrations of fibrinogen increased in men by 0.12 g/L (95% CI: 0.05–0.19) for each 
pound decrease in birth weight, but not in women [18]. In the MIDSPAN Family Study, 
which included 1663 adults with ages from 30 to 59, there was a negative association 
between birth weight and CRP: the authors reported a 10.7% increase in CRP for each 1 kg 
decrease in birth weight, both in men and women [19].
None of these studies attempted, as we have done, to combine a series of markers of 
inflammation or endothelial activation to obtain a more complete picture. The relatively 
weak correlations that exist between different inflammatory markers, and the weaker 
associations found with individual markers when compared to the highly significant ones 
found with the score, emphasize the difficulty of characterizing the state of systemic 
inflammation and endothelial activation with individual markers.
The choice of these markers was governed chiefly by their availability in the ARIC cohort. 
Most are well described as measures of either inflammation or endothelial activation. Two 
of the markers, albumin and aPTT, both of which were less clearly associated with birth 
weight, were maintained in the score as having been selected a priori. Albumin is a negative 
acute phase reactant, as its production decreases during the acute phase reaction. Little has 
been published concerning a shortened aPTT as a marker of subclinical inflammation/
endothelial activation. A quicker aPTT represents a tendency toward hypercoagulability via 
the intrinsic pathway [20], which has been described as occurring, in part, due to endothelial 
cell activation [21] Many of these markers and a similar score were predictors of incident 
diabetes in the ARIC cohort [22–24].
A large body of evidence has accumulated in recent years relating atherosclerosis to 
inflammatory pathogenic mechanisms. Markers of inflammation are important correlates of 
the metabolic syndrome [25–27] and predictors of the risk of diabetes, weight gain in 
middle-age, hypertension and cardiovascular events [8,28,29]. Low birth weight has also 
been linked to impaired endothelial function in children [30] and, although not always 
consistently, to numerous chronic conditions in adulthood, including fatal and non-fatal 
CHD and stroke, hypertension, hypertriglyceridemia and low HDL-C, diabetes mellitus, and 
obesity [31–38].
The mechanisms through which the fetal environment may increase cardiovascular risk are 
still under debate. We hypothesize that one possible mechanism is a programming of the 
innate immune system. Long-term effects of early life deprivation on immune functioning 
have been previously reported. In adolescents, low birth weight has been associated with a 
less intense immune response to typhoid immunization [39]. In regions of rural Africa with 
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significant seasonal disparities in food availability, the season of birth is a strong predictor 
of adult fatal infections and death. In one report, individuals born during the hungry season 
(as compared to those born during harvest season) had a 10 fold increased risk of death after 
25 years of age [40,41].
Programming of the immune system could result in a longstanding up regulation of pro-
inflammatory gene expression. Gene expression is increasingly being shown to be a very 
dynamic phenomenon, involving qualitative and quantitative alterations to promote 
functional adaptation to environmental changes [42–44]. For example, the expression of 
numerous clusters of genes is altered in different phases of atherosclerotic plaque formation 
and macrophage migration, in what has been described as an “endothelial cell pro-
inflammatory phenotype” [42].
Our results thus present evidence consistent with the hypothesis that undernutrition and 
other stressors during fetal development cause alterations of gene expression, which leads to 
a chronic, low grade state of inflammation that could predispose to the development of the 
metabolic syndrome, diabetes and CHD. An alternative hypothesis might be that linked 
genes affect both birth weight and inflammation, but low birth weight does not directly 
affect inflammation.
Limitations of our study merit discussion. Being observational in nature, residual 
confounding, especially by socioeconomic status, cannot be ruled out as an explanation for 
the findings. The proportion of individuals not knowing their birth weight suggests that 
misclassification is possible. In fact, in related work based on this cohort, the categorized 
exact birth weight in ARIC corresponded more closely to distributions found in national 
vital statistics than did the qualitative birth weight [45]. Also, those who recalled exact birth 
weight were more likely to be white, female, and to have higher levels of education than 
those who provided qualitative birth weight [37]. However, the fact that similar results were 
obtained when only those reporting an exact weight were analyzed is reassuring. It is quite 
possible that given misclassification of birth weight, true associations may be larger than 
those that we report, as associations were somewhat stronger in analyses including only 
those who reported their exact birth weight. Furthermore, some authors suggest that 
maternal malnutrition during gestation may result in specific alterations of body proportions, 
permanently affect adult health without affecting significantly the size of the baby at birth 
[46]. This implies that the long-term consequences of a stressful uterine environment will be 
underestimated if these are solely based on the size at birth, although birth weight is the 
most practical and, in many studies, the only feasible, measure of fetal growth [47]. Residual 
confounding due to subclinical disease is another possibility. However, this appears unlikely 
to have occurred, since the association between birth weight and the score increased after 
adjustment for overall and central obesity, conditions associated with a chronic 
inflammatory state.
The lack of association between birth weight and the inflammatory/endothelial activation 
score in African-Americans could be due to insufficient statistical power, given the small 
numbers of African-American individuals in our study, or to greater birth weight 
misclassification in this group. Nevertheless, it is important to consider the possibility that 
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programming of genes responsible for inflammatory and endothelial activation in response 
to intrauterine environmental stress may vary according to ethnicity. Differences between 
whites and African-Americans in terms of inflammation and related chronic disease have 
been reported. For example, African-Americans showed a significantly higher 
inflammatory/endothelial activation score in ARIC, and are known to have a different 
composition of the metabolic syndrome elements than whites [48]. In the ARIC cohort, the 
association of inflammation markers with incident diabetes was present in whites, but not in 
African-Americans [22].
In conclusion, low birth weight predicted a greater systemic inflammation and endothelial 
activation in middle-aged adults, permitting speculation that fetal stressors may result in 
altered gene expression (fetal programming) producing a hyper-responsive innate immune 
system. This state may help explain reported association of low birth weight with insulin 
resistance, elements of the metabolic syndrome and ischemic heart disease, all known today 
as conditions having important inflammatory components.
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Frequency of scores of inflammation and endothelial activation according to low (grey 
columns) and medium/high (white columns) birth weight.
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Table 1
Distribution of sociodemographic characteristics and cardiovascular risk factors by birth weight as a 
dichotomous variable, adjusted by gender, race and age.
Birth weight P value
Low (n = 349) Medium or high (n = 9460)
Age — years 54.1±0.30 53.8±0.06 0.42
Gender — female 278 (79.4) 5225 (55.2) <0.001
Ethnicity — African-American 85 (22.7) 1792 (19.0) 0.09
Height — cm 165.5±0.33 168.7±0.06 <0.001
Weight — kg 74.2±0.79 78.4±0.15 <0.001
BMI — kg/m2 27.0±0.27 27.5±0.05 0.06
WHR 0.93±0.004 0.92±0.001 0.34
Systolic BP — mm Hg 122.2±0.88 119.1±0.17 <0.001
Diastolic BP — mm Hg 73.3±0.53 73.0±0.10 0.52
Cigarette years of smoking 283.2±20.44 279.6±3.91 0.79
Current smoker 80 (23.2) 1982 (0.9) 0.33
Usual ethanol intake — g/week 36.3±4.58 41.7±0.88 0.23
Current drinker Education level 166 (51.6) 5692 (60.0) 0.003
 Advanced
a 96 (29.4) 3806 (40.2) <0.001
 Intermediate
b 170 (47.4) 4001 (42.3) 0.07
 Basic
c 83 (23.1) 1651 (17.5) 0.01
Hypertension 127 (35.6) 2826(29.9) 0.03
Prevalent CHD 6 (2.7) 314 (3.4) 0.57
Diabetes 35 (9.8) 812 (8.6) 0.43





Physical activity at work — points 2.15±0.05 2.21±0.01 0.21
Leisure time physical activity — points 2.39±0.03 2.42±0.01 0.29
BMI = body mass index, WHR = waist to hip ratio, BP = blood pressure CHD = coronary heart disease.
Variables expressed as mean±Standard Error of Mean or N (%).
a






Excluding those with diabetes.
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Table 3
Risks of a high inflammation and endothelial activation score for those with low birth weight.

















Adjusted through robust poisson regression for gender, ethnicity, age, study center, educational level, drinking and smoking status, and amount 
smoked.
b
Adjusted additionally for BMI and WHR.
c
Adjusted as in model 1, except not for gender.
d
Adjusted as in overall, except not for ethnicity.
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